COMPANY NEWS

3D Signatures arranges $105K loan; CEO, CFO resign

September 17, 2018
3D SIGNATURES INC. ANNOUNCES $105,000 LOAN AND CHANGES TO ITS BOARD OF DIRECTORS AND MANAGEMENT 3D Signatures Inc. has secured...
Read More

3D SIGNATURES ANNOUNCES INTENTION TO FILE FOR BANKRUPTCY

May 31, 2018
TORONTO, May 31, 2018 3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a...
Read More

3D SIGNATURES STRENGTHENS ITS INTELLECTUAL PROPERTY WITH NEW PATENTS ISSUED FOR TESTS IN ALZHEIMER’S DISEASE, HODGKIN’S LYMPHOMA AND MULTIPLE MYELOMA

May 10, 2018
TORONTO, May 10, 2018 3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL™ Test for Hodgkin’s Lymphoma

April 3, 2018
TORONTO, April 3, 2018 3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

March 28, 2018
TORONTO, March 28, 2018 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer

March 6, 2018
TORONTO, March 06, 2018 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

March 2, 2018
TORONTO, ON, March 1, 2018 3D Signatures Inc. (TSXV: DXD; OTCQB: TDSGF; FSE: 3D0) (the "Company" or "3DS"), a personalized...
Read More

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HLᵀᴹ Test for Hodgkin’s Lymphoma

February 20, 2018
TORONTO, February 20, 2018 3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a...
Read More

3D Signatures Inc. Announces Changes To Its Board of Directors

February 13, 2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, February 12, 2018 - 3D Signatures...
Read More

3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement

December 6, 2017
TORONTO, December 5, 2017 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES 3D Signatures...
Read More
1 2 3 9